Second Malignant Neoplasms in Pediatric Oncology Patients: A Single Center Experience

Tanyildiz H. G., Yesil S., Tekgunduz S. A., Candir M. O., Toprak S., Bozkurt C., ...Daha Fazla

GAZI MEDICAL JOURNAL, cilt.28, sa.3, ss.164-167, 2017 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 28 Sayı: 3
  • Basım Tarihi: 2017
  • Doi Numarası: 10.12996/gmj.2017.50
  • Dergi Adı: GAZI MEDICAL JOURNAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.164-167
  • Anahtar Kelimeler: Cancer, childhood, secondary tumor, CHILDHOOD-CANCER SURVIVOR, OF-THE-LITERATURE, HODGKINS-DISEASE, 5-YEAR SURVIVORS, FOLLOW-UP, CHILDREN, LEUKEMIA, THERAPY, TRIAL, RISK
  • İstanbul Üniversitesi Adresli: Hayır

Özet

Objective: The pediatric malignancy survival rate has increased with new and intensive treatment modality advancements. This has led to an approximately 70% chance of surviving more than 5 years in children diagnosed with cancer. However, the secondary tumor incidence has also increased with these advances. The patient's quality of life, late side effects, and prevention of secondary malignancies in the future are as important as treating the primary tumor in pediatric cancer patients.